OTLK - Outlook Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - OTLK (1649989)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-09-26
OTLKKenyon Lawrence ACFOP - Purchase$5.69+5,0005,946+529%+$28,446
D
2024-04-15
OTLKSyntone Ventures LLC10%P - Purchase$0.00+714,2861,705,438+72%+$0
2024-03-28
OTLKHaddadin Yezan MuntherDirP - Purchase$11.82+1,8825,049+59%+$22,242
2024-03-07
OTLKEvanson JeffChief Commercial OfficerP - Purchase$0.42+62,484808,459+8%+$26,243
2023-04-20
OTLKDagnon TerryChief Operations OfficerS - Sale$1.14-520,000653,058-44%-$590,200
2023-01-20
OTLKEvanson JeffChief Commercial OfficerS - Sale$1.11-267,000745,975-26%-$296,370
M
2023-01-17
OTLKEvanson JeffChief Commercial OfficerS - Sale$1.24-164,1551,012,975-14%-$203,726

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top